Denver's Palantir closes out 2020 with nearly $150M in new government contracts

PALANTIR svbj 004 062420
Palantir, which recently relocated to Denver, builds platforms for integrating, managing, and securing data on top of which applications are layered for fully interactive human-driven, machine-assisted analysis.
Tomas Ovalle | Silicon Valley Business Journal
Nick Greenhalgh
By Nick Greenhalgh – Reporter/Colorado Inno associate editor, Denver Business Journal

As the year comes to a close, Denver's newest tech giant is racking up new government contracts.

Palantir Technologies, a $20 billion data-analysis software firm that moved to Denver in August, closed two deals worth nearly $150 million at the end of December.

The first contract came as the U.S. Army’s Program Executive Office for Enterprise Information Systems opted to execute the second year of its partnership with the company on the Army Vantage program, for a total price of $113.8 million for the year.

In December 2019, the U.S. Army selected Palantir for a $458 million production agreement to power Army Vantage, a comprehensive data analytics platform to facilitate data-driven decision making. The contract was for a base year and three option years, and Palantir was awarded $110 million at the time for the base year.

In the last year, Army Vantage has helped leaders make data-driven decisions in the fight against Covid-19.

The second contract is a two-year deal worth up to $31.5 million with the U.K.’s National Health Service (NHS) to provide a software platform for secure, reliable and timely processing of data to enable NHS decision-makers to best plan the use of resources and improve patient care.

NHS personnel will use Palantir's software to understand how Covid-19 is spreading, identify risks to particularly vulnerable populations, proactively increase health and care resources in emerging hot spots, ensure critical equipment is supplied to the facilities with the greatest need and divert patients and service users to the facilities that are best able to care for them.

The NHS will also use Palantir as part of its planning and operational roll-out of the U.K.’s vaccine program.

Related Content